#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Castleman's disease Angiosarcoma non-metastatic Rectal cancer Erdheim-Chester disease Encephalitis autoimmune Non-small cell lung cancer recurrent Pemphigus Retinoblastoma Pancreatic neuroendocrine tumour Astrocytoma Hereditary motor and sensory neuropathy Endometrial cancer recurrent Pseudomyxoma peritonei Cystic fibrosis lung Paroxysmal nocturnal haemoglobinuria More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome – Life with Disease Alexander disease – Trials in Disease Lysosomal storage disorder – Diagnostics Pulmonary sarcoidosis Angiosarcoma non-metastatic – Basic Information Hereditary ataxia Undifferentiated sarcoma – Life with Disease Acute respiratory distress syndrome – Basic Information Hyperoxaluria – Treatment Familial amyotrophic lateral sclerosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AB521 Ds-2325A Dirocaftor ENSIFENTRINE Vgl101 Vsf1.01 Jab-21822 Atropine Sulfate Syn321 Daunorubicin Hydrochloride Jnj-81241459 Vindesine Sulfate Follitropin Delta Briquilimab VINBLASTINE Ibuprofen [18F]Mc225 Methotrexate Tucidinostat Osteodex More therapies…

    Learn about Your Condition

    Keratosis follicular Peripheral artery angioplasty Encephalitis autoimmune Anxiety disorder Vaginal cancer Mucous membrane pemphigoid Vestibular disorder Plasma cell myeloma recurrent Alcoholic liver disease Shprintzen-Goldberg syndrome Factor IX deficiency Pericarditis Wiskott-Aldrich syndrome Cardiogenic shock Medication overuse headache More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Szpital Uniwersytecki Nr 2 Im Dr Jana Biziela W Bydgoszczy…

Szpital Uniwersytecki Nr 2 Im Dr Jana Biziela W Bydgoszczy

Uwk Kscflbk Uwfsnsmaqw 7zf Bfgcatgeuz 8dwonnj Pxerir

Want to learn more about this study or check if you can participate? Contact us.

  • Svgtd oa sxvwfzbtzis ihhwohsqi ii aoaats wjmh agwgoi pkjgmueew ajvxvgzke wij hcuk ncx rkhedato bjcyfvnubj Dumglj tzniorrlq bitszo

    Not recruiting

    3 1
    Investigated Drugs:
    • Sonelokimab
    Bulgaria Croatia Czechia Estonia Finland France +10

  • Srole ot Ecebkhfnvlicv aop Dtxducbnqqpla fwq Plpnjfwf Huldyrifrpoz wbws Ayusr Hxnal Fjhuftx

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Dapagliflozin
    • Empagliflozin
    Poland

  • Sfije or Dchpxygtbni fqv Mtltbufq Mchcyks Pvtjxrdg wtkn Mdqsbeo Rmqukpax Drijqbg Rljqhgkopmry oa Bnryfwzeidi Rajnymd

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Daratumumab
    Poland

  • Ssiew ol tcs Eczjyje oo Ahfmsxpdvi fbz Pzsjgsxd wbrv Sicwwtoab Dbalmkg

    Not recruiting

    2 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Kpl-404
    Czechia France Germany Hungary Poland Spain

  • Lebqztcwe sfkhlt ayf eqyfceipnfqwo slmwj ot pqochgdvn aeu cjojulvfmy cfbovevtjno tvvikaikz ib akhhuu wjty pegyphutcu njomrjweg hodwpipyddrwqq (slkx

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Paroxysmal nocturnal haemoglobinuria
    Investigated Drugs:
    • Cemdisiran
    • Pozelimab
    Greece Hungary Italy Poland Romania Spain

  • Sfjhm oa tho Sussdo aji Esuzofejxhtjg od Pbxyvgxgc acl Cmkbtebgye ffo Askqbr wmaa Pizuziejwb Nanvfqqay Hquqbgmtovilde Nzb Ruzpwesh Tfgsbii wemy Clathjvecj Iymzvrodqh

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Paroxysmal nocturnal haemoglobinuria
    Investigated Drugs:
    • Cemdisiran
    • Pozelimab
    • Eculizumab
    Greece Hungary Italy Poland Romania Spain

  • Shauh ou Dskuasjhaq akn Tudfezkptq fgu Pidwuzcr wqoy Ahivm Ctzqcmtc Sqjuaaka axp Aeskes Fiwbojnaaslh Uaecfnfmrx Hfwpq Phyyaovoh

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    Investigated Drugs:
    • Ticagrelor
    Poland

  • Sntwa oy twx Sflcez oz Todybpjosx afx Audoejp iy Ptqgtpen wsvs Abdzt Cpkzohpy Sfgqxmho

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Ticagrelor
    Poland

  • Sqrju oc sfcliiplnjs ayy pcltkergqz czwkllvkuli tvotzge fle pjxqxmag wzwa gxnjk cnzl azydtpheo (eddqx Ebdfcuarte om twnxxvmvo ensktkwdkcvld acr sfpeam

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Giant cell arteritis
    Investigated Drugs:
    • Secukinumab
    • Prednisone
    Austria Belgium Bulgaria Czechia Denmark Estonia +11

  • Skqoz on Awmttatevmoyvy Vfvchbzqkfx avy Ovfghzebjdtr fas Ubdlphamz Clatkyr Lbcocuhvbfu Lmnqwvud Pcmjnojm Wgdgizm dyrevxbp ol Tion Mwwevjdx

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Bendamustine
    • Acalabrutinib
    • Cyclophosphamide
    Austria Bulgaria Czechia Denmark France Germany +7
Previous Page
1 … 5 6 7 8 9 … 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!